Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

ASH 2019 Update in MPN: Triple Negative ET, Ropeginterferon in PV & Fedratinib, Luspatercept and Emerging Epigenetic-based Therapies in Myelofibrosis

32 views
March 9, 2020
Comments 0
Login to view comments. Click here to Login